talkhere
1+ Views

CLA (acide linoleique conjugue): perte de graisse et gain musculaire



le CLA (acide linoleique conjugue) est un acide gras naturel, similaire a l'acide gras omega-6, mais avec des avantages pour la peau et une perte de poids. C’est l’un des "bonnes graisses", present dans les aliments comme la viande et les produits laitiers, mais uniquement a de faibles niveaux.
Ironiquement, le b?uf et les produits laitiers sont les memes aliments qui sont egalement riches en ce que nous considerons "mauvaises graisses" ou graisses saturees, il est donc problematique de consommer suffisamment de cet acide gras uniquement a partir de l'alimentation.

De facon aussi sarcastique, bien que l'acide linoleique soit une graisse, des etudes montrent que 1,4 a 3,0 grammes par jour de linoleique conjugue entrainera une perte totale de graisse corporelle 1,2.
Et pourtant, pour que cet acide linoleique penetre naturellement dans votre systeme, vous devez consommer plus de 2 livres de viande, une livre de fromage ou 100 onces de lait par jour!
Cependant, l'augmentation de la consommation de cla ne doit pas provenir des produits laitiers ou du b?uf, car les avantages de l'acide peuvent etre obtenus grace a la supplementation.

Pourquoi CLA est-il bon?

Il peut sembler etrange qu'un acide gras puisse aider a reduire la graisse corporelle tout en augmentant la masse musculaire, mais c'est ce que la science suggere!
Bien que techniquement un gras trans, cette variete d'acide gras est naturellement presente dans nos sources alimentaires et differe des gras trans produits industriellement, comme l'huile vegetale. Comme de nombreux agents naturels, l'acide linoleique a Read more une place organique et importante dans notre alimentation.


Telechargez les 5 regimes de perte de poids les plus efficaces

Special pour les femmes qui travaillent

Margarita P. avait deja fait tous les regimes Internet. J'ai perdu du poids mais je suis remonte a l'etage; J'etais desespere ...
L'annee derniere, elle et 1115 autres femmes mexicaines ont perdu entre 10 et 15 kilos de graisse abdominale et ont augmente leur metabolisme naturellement de 77% avec cet eBook.


Cliquez ici pour vous envoyer un eBook

Cette graisse peut-elle m'aider a perdre du poids?

Bien que l'acide linoleique conjugue est un gras trans, il y a un but! Plus precisement, cet acide gras aide a reduire le besoin de manger des aliments inutiles et inhibe la production de graisses supplementaires. Fondamentalement, cet acide est un type special de graisse qui remplace notre besoin d'autres graisses malsaines.
L'acide linoleique conjugue nous dit de rester mince et propre , nous aider a bruler des calories qui existent deja, plutot que de desirer des calories supplementaires inutiles.
Une etude recente portant sur l'effet de 4,2 grammes de ce gras trans par jour chez 53 individus en bonne sante a montre une diminution significative (3,8 pour cent) de la graisse corporelle par rapport aux individus qui n'en prenaient pas.
Retrouvez ici le Supplements dont vous avez besoin pour perdre du poids
Une autre etude sur les populations obeses et en surpoids a montre qu'au moins 3,4 grammes d'acide conjugue par jour sur une periode de 12 semaines etaient vraiment necessaires pour voir une reduction significative de la graisse corporelle. En d'autres termes, sans apport de ce gras trans, il n'y a pas eu de perte de graisse importante!

Quels sont les avantages de cet acide pour l'entrainement?

Un essai qui a surveille les avantages de la supplementation en acide linoleique conjugue a montre que la consommation de 7,2 grammes par jour, accompagnee d'un regime de musculation, augmentait la circonference corrigee des bras, les gains de presse des jambes et la masse corporelle totale. Par rapport a un groupe placebo qui a effectue la meme routine sans cla.

Y a-t-il des avantages supplementaires de l'acide linoleique?

La recherche montre qu'il existe sont aussi bienfaits de cet acide gras pour la sante de la peau , en plus des avantages pour la perte de poids. Pour cette raison, cet acide a ete ajoute a un certain nombre de produits de soins de la peau populaires.
Mais vous n'avez pas a acheter ces produits pour obtenir les avantages, tant que vous les completez deja.
Visitez notre Zentenoshop.com Magasin en ligne

Pourquoi n'ai-je pas assez de CLA?

Beaucoup de gens consomment deja beaucoup de viande et de produits laitiers, il serait donc logique de penser que la quantite d'acide gras dans leur corps devrait etre suffisante pour survivre.
Malheureusement, la production de viande et de lait a change au fil des ans. La viande industrialisee non nourrie a l'herbe contient beaucoup moins d'acide linoleique que la viande nourrie a l'herbe, tandis que les produits laitiers provenant de vaches non nourries a l'herbe contiennent egalement moins d'acide que les produits laitiers provenant de vaches nourries a l'herbe.

Comment dois-je le prendre?

Comme avec tout supplement, certains types d'acides gras, surtout s'ils ne sont pas pris comme recommande, peuvent etre difficiles a traiter pour le foie.
Ce type d'acide gras peut egalement creer un desequilibre dans les graisses du lait maternel.Il est donc recommande aux meres qui allaitent de reporter l'administration de ces supplements jusqu'a ce que leur enfant ait depasse l'age de l'allaitement.
Je vous recommande de lire: Cell-Tech bien sur, cela fonctionne - Connaitre ses avantages et inconvenients
En dehors de cela, la prise de cet acide gras est simple: les capsules d'un supplement d'acide linoleique conjugue, aux doses recommandees par le fabricant, doivent etre prises un peu avant ou pendant un repas. Les capsules sans stimulant se combinent bien avec d'autres produits.
talkhere
0 Likes
0 Shares
Comment
Suggested
Recent
Cards you may also be interested in
Protein Engineering : Future, Trends, And Scope
The growth of this market is majorly driven by factors such as the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies.  The rational protein design segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the increasing use and continuous upgrades of bioinformatics platforms and software for protein analysis.  The global market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the global market, closely followed by Europe.  Factors such as the presence of well-established CROs, rising R&D expenditure, and the availability of the latest techniques and instruments for drug discovery research are responsible for the large share of the North American market. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=898  Monoclonal antibodies accounted for the largest share of the protein engineering market in 2019, majorly due to the high and growing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases.  The rational protein design segment accounted for the largest share of the market, majorly due to the increasing use and continuous upgrades of bioinformatics platforms and software for protein analysis.  The protein engineering market is segmented into biopharmaceutical companies, contract research organizations, and academic research institutes. Biopharmaceutical companies use protein engineering products extensively in their drug discovery and development activities as these products help in designing models to develop a broad range of protein-based drugs. As a result, biopharmaceutical companies were the largest end-users in this market in 2019.  The major companies operating in the global protein engineering market include Thermo Fisher Scientific (US), Danaher Corporation (US), Agilent Technologies (US), and Bio-Rad Laboratories (US).  Market Research Developments: In 2019, Creative Biolabs (US) launched the cd25 monoclonal antibody. In 2019, Waters Corporation (US) launched Vanguard FIT Cartridge Technology. In 2019, Agilent Technologies (US) acquired BioTek Instruments (US), which helped the company to expand its expertise in cell analysis and establish its position in the immuno-oncology and immunotherapy markets. In 2019, Merck KGaA signed a license agreement with Amunix Pharmaceuticals, Inc. (US). Under this agreement, Amunix will gain the rights to develop therapeutics using the protease-triggered immune activator (ProTIA) technology platform.
Health News: Ethical Issues Related To Embryonic Stem Cell Research
Research in cell biology necessitates the use of animals and humans, as animal and human cells are used in gene therapy studies that involve the recombination of genes and stem cell research therapies. These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs that may harm animals and humans. In addition, stem cell research studies use human embryos for clinical applications that often lead to the destruction of the embryos.  The presence of these ethical concerns and restrictions on the use of cells for research is limiting cell biology research to a great extent in various countries across the globe. This, in turn, is expected to restrict the growth of the stem cell assays market.  In order to monitor these activities, strict regulations have been formulated by ethical authorities, such as the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines, and Healthcare Products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research.  For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47610330 The viability/cytotoxicity segment accounted for the largest market share of the global stem cell assay market in 2017. Factors driving the growth of this segment include the widespread use of viability/cytotoxicity assays in stem cell research activities. By cell type, the market is segmented into adult stem cells and human embryonic stem cells. The adult stem cells segment accounted for the largest market share of the global stem cell assay market in 2017. Increasing research on adult stem cells and less stringent regulations are the key factors driving the growth of the adult stem cell market. On the basis of product & service, the stem cell assay market is segmented into instruments, kits, and services. The instruments segment is estimated to account for the largest share of the global stem cell assay market during the forecast period. The growth of this segment is primarily attributed to the ongoing technological innovations in stem cell instruments and the rising number of stem cell research activities across the globe.
Without Conviction Animal-Cruelty Case To End: Animal Treatment
The growth of the animal treatment market can be attributed to increasing government initiatives, which ensure maximum preventive healthcare for animals. A majority of the developed economies have norms that impel owners to have pet insurance.  By animal type, the horse's segment is expected to register the highest growth rate during the forecast period. Based on animal type, the animal treatment market is segmented into dogs, cats, horses, cattle, pigs, and poultry. The percentage of medical treatment received by horses is predicted to grow by 2024. In several countries, racehorses are considered to be of economic importance. Therefore, it becomes imperative for caretakers to provide maximum preventive as well as long-term veterinary care to equine species, as negligence pertaining to equine species may have an economic impact. On average, over 70-75% of the horses receive maximum preventive healthcare.  By treatment type, the veterinary care segment is expected to register the highest growth rate in the forecast period. Based on treatment type, the animal treatment market is segmented into no medicalization, basic medicalization, and veterinary care. Over the years, the demand for veterinary care services has increased. Veterinary clinics and hospitals in developed as well as developing countries are well-equipped with the necessary equipment for diagnosis and treatment. For instance, Banfield Hospital in the US is one of the most sophisticated hospitals that provides diagnostic tests for animals. North America is the largest market for animal treatment North America is the largest market in terms of the consumption of veterinary products. People are well versed with animal healthcare regulations, and hence high-quality care is provided to animals in this region.  Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180479252  However, the animal treatment market has become saturated in the US, as the number of veterinary visits has stabilized. On the contrary, the animal treatment rate in European countries has increased. The increasing standard of living and the growing number of veterinarians providing exceptional medical services to animals are the major factors driving the European animal treatment market. Prominent players in the animal treatment market are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Abaxis (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), and Heska Corporation (US).